RecruitingNot ApplicableNCT03249519

Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer

Multimodal Therapy of Advanced Cervical Cancer With Radiotherapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia


Sponsor

University of Erlangen-Nürnberg Medical School

Enrollment

999 participants

Start Date

Aug 1, 2017

Study Type

INTERVENTIONAL

Conditions

Summary

The combination of radiation therapy or chemoradiation with Interstitial brachytherapy for advanced cervical cancer (pN+, FIGO-Stage II B - IV A is standard of therapy. The radio- and chemosensitive effect of an additional hyperthermia might improve the clinical outcome.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether adding heat treatment (hyperthermia) to standard radiation and chemotherapy improves outcomes for women with advanced cervical cancer. **You may be eligible if...** - You have been confirmed (by tissue sample) to have cervical cancer - Your cancer is at an advanced stage (Stage IIB–IVA) or is at an earlier stage but surgery is not an option - You have not had the cancer spread to distant organs (except nearby lymph nodes) - You are 18 or older and in a reasonable general health state **You may NOT be eligible if...** - You have uncontrolled heart disease, heart failure, recent heart attack, or a pacemaker - You have metal implants larger than 2 cm in the pelvis - You have an active or treatment-resistant bladder infection - You have an immune deficiency condition - You are pregnant or breastfeeding - You are unwilling to use effective contraception during and after treatment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONRadiation

50.4 Gy

RADIATIONbrachytherapy

35-40 Gy

DRUGCisplatin

weekly 40 mg/m\^2 (6cycles)

OTHERHyperthermia

10 times


Locations(1)

Universitätsklinikum Erlangen, Strahlenklinik

Erlangen, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03249519


Related Trials